Drug Information Analysis Service

Marliss EB Nakhooda AF Poussier P Sima AF . The diabetic syndrome of the ‘BB’ Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia 1982; 22: 225–9.

Nerup J Anderson O Bendixen G Egeberg J Poulsen JE . Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes 1982; 20: 424–7.

Bottazo GF Dean BM McNally JM Mackay EH Swift PGF Gamble DR . In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetes mellitus. N Engl J Med 1985; 313: 353–60.

Boitard C Chatenoud LM Debray-Sachs M . In vitro inhibition of pancreatic β cell function by lymphocytes from diabetics with associated autoimmune disease: a T cell phenomenon. J Immunol 1982; 129: 2529–31.

Feutran G Quiniou-Debrie MC Debray-Sachs M Immunologic effects of cyclosporin in type I diabetes mellitus. Transplant Proc 1986; 18: 817–8.

Laupacis A Stiller CR Gardell C Cyclosporine prevents diabetes in BB Wistar rats. Lancet 1983; 1: 10–1.

Like AA Dirodi V Thomas S Guberski DL Rossini AA . Prevention of diabetes mellitus in the BB/W rat with cyclosporine A. Am J Pathol 1984; 117: 92–7.

Mori Y Suko M Okudaira H Preventative effects of cyclosporine on diabetes in NOD mice. Diabetologia 1986; 29: 244–7.

Stiller CR Dupre J Gent M Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223: 1362–7.

Assan R Debray-Sachs M Laborie C Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet 1985; 1: 67–71.

Mirouze J Selam JL Pham TC Mendoza E Orsetti A . Sustained insulin-induced remission of juvenile diabetes by means of an external artificial pancreas. Diabetologia 1978; 14: 223–7.

Feutran G Assan R Karsenty G Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Lancet 1986; 2: 119–24.

Humes HD Jackson NM O'Connor RP Hunt DA White MD . Pathogenetic mechanism of nephrotoxicity: insights into cyclosporin nephrotoxicity. Transplant Proc 1985; 17 (4) (suppl l): 51–62.

Hamilton DV Evans DB Thiru S . Toxicity of cyclosporin A in organ grafting. In: White DJG , ed. Proceedings of an international conference on cyclosporin A. New York: Elsevier, 1982: 393–403.

Brayman KL Armstrong J Barker CF Naji A . Intermittent cyclosporine administration and prevention of diabetes in the BB rat. Transplant Proc 1986; 18: 1545–7.

Guilleminault C Van Den Hoed J Mitler MM . Clinical overview of the sleep apnea syndromes. In: Guilleminault C Dement WC , eds. Sleep apnea syndromes. New York: Alan R. Liss, 1978: 1–12.

Kales A Vela-Bueno A Kales JD . Sleep disorders: sleep apnea and narcolepsy. Ann Intern Med 1987; 106: 434–43.

Gotfried MH Quan SF . Obstructive sleep apnea: pathogenesis and treatment. Lung 1984; 162: 1–13.

Guilleminault C Dement WC . Sleep apnea syndromes and related sleep disorders. In: Williams RL Karacan I Moore CA , eds. Sleep disorders. Diagnosis and treatment. New York: John Wiley & Sons, 1988: 47–71.

Kurtz D Krieger J . Analysis of apnea in sleep apnea. In: Guilleminault C Dement WC , eds. Sleep apnea syndromes. New York: Alan R. Liss, 1978: 150–3.

Lombard RM Zwillich CW . Medical therapy of obstructive sleep apnea. Med Clin North Am 1985; 69: 1317–35.

Sullivan CE Issa FG . Obstructive sleep apnea. Clin Chest Med 1985; 6: 633–50.

Robinson RW Zwillich CW . The effects of drugs on breathing during sleep. Clin Chest Med 1985; 6: 603–14.

White DP . Central sleep apnea. Clin Chest Med 1985; 6: 623–31.

Clark RW Schmidt HS Schaal SF Sleep apnea: treatment with protriptyline. Neurology 1979; 29: 1287–92.

Conway WA Zorick F Piccione P Roth T . Protriptyline in the treatment of sleep apnoea. Thorax 1982; 37: 49–53.

Brownell LH West P Sweatman P Protriptyline in obstructive sleep apnea. N Engl J Med 1982; 307: 1037–42.

Brownell LH Perez-Padilla R West P Kryger MH . The role of protriptyline in obstructive sleep apnea. Bull Eur Physiopathol Respir 1983; 19: 621–4.

Smith PL Haponik EF Allen RP Bleecker ER . The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983; 127: 8–13.

Stepanski EJ Conway WA Young DK A double-blind trial of protriptyline in the treatment of sleep apnea syndrome. Henry Ford Hosp Med J 1988; 36: 5–8.

Whyte KF Gould GA Airlie AAM Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988; 77: 463–72.

Katsantonis GP Schweitzer PK Branham GH Management of obstructive sleep apnea: comparison of various treatment modalities. Laryngoscope 1988; 98: 304–9.

Rajagopal KR Abbrecht PH Jabbari B . Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986; 90: 815–21.

Ohshima H . Medroxyprogesterone acetate and sleep apnea. Jpn J Psychiatry Neurol 1987; 41: 645–50.

Orr WC Imes NK Martin RJ . Progesterone therapy in obese patients with sleep apnea. Arch Intern Med 1979; 139: 109–11.

Strohl KP Hensley MJ Saunders NA Progesterone administration and progressive sleep apnea. JAMA 1981; 245: 1230–2.

Hensley MJ Saunders NA Strohl KP . Medroxyprogesterone treatment of obstructive sleep apneas. Sleep 1980; 3: 441–6.

Brandt NJ Terenius L Jacobsen BB Hyper-endorphin syndrome in a child with necrotizing encephalomyopathy. N Engl J Med 1980; 303: 914–6.

Santiago TV Remolina C Scoles V Edelman NH . Endorphins and the control of breathing. Ability of naloxone to restore flow-resistive load compensation in chronic obstructive pulmonary disease. N Engl J Med 1981; 304: 1190–5.

Diamond E Druz W D'Souza V Sharp JT . Effect of naloxone in obstructive sleep apnea (abstract). Am Rev Respir Dis 1982; 125: 235.

Guilleminault C Hayes B . Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull Eur Physiopathol Respir 1983; 19: 632–4.

Atkinson RL Suratt PM Wilhoit SC Recant L . Naloxone improves sleep apnea in obese humans. Int J Obes 1985; 9: 233–9.

Suratt PM Wilhoit SC Brown ED Inley LJ . Effect of doxapram on obstructive sleep apnea. Bull Eur Physiopathol Respir 1986; 22: 127–31.

Houser WC Schlueter DP . Prolonged doxapram infusion in obesity-hypoventilation syndrome. JAMA 1978; 239: 340–1.

Hunt CE Inwood RJ Shannon DC . Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. Am Rev Respir Dis 1979; 119: 263–9.

Stanley NN . Almitrine: a promising new drug for sleep hypoxia. Lancet 1981; 2: 1105–6.

Krieger J Mangin P Kurtz D . Effects of a ventilatory stimulant, almitrine bismesylate, in the sleep apnea syndrome. Curr Ther Res 1982; 32: 697–705.

Krieger J Mangin P Kurtz D . Effects of almitrine in the treatment of sleep apnea syndromes. Bull Eur Physiopathol Respir 1983; 19: 630.

Douglas NJ Connaughton JJ Morgan AD Effect of almitrine on nocturnal hypoxaemia in chronic bronchitis and emphysema, and in patients with central sleep apnoea. Bull Eur Physiopathol Respir 1983; 19: 631.

White DP Zwillich CW Pickett CK Central sleep apnea. Improvement with acetazolamide therapy. Arch Intern Med 1982; 142: 1816–9.

Tojima H Kunitomo F Kimura H Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 1988; 43: 113–9.

Sharp JT Druz WS D'Souza V Diamond E . Effect of metabolic acidosis upon sleep apnea. Chest 1985; 87: 619–24.

Espinoza H Antic R Thornton AT McEvoy RD . The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1987; 136: 80–4.

Sullivan CE Issa FG Saunders NA Berthon-Jones M . Pathophysiology of sleep apnea. In: Saunders NA Sullivan CE , eds. Sleep and breathing. New York: Marcel Dekker, 1984: 299–363.

Mayer J Fuchs E Hugens M Long term theophylline therapy of sleep apnea syndrome (SAS) (abstract). Am Rev Respir Dis 1984; 129 (suppl A): 252.

Rubin A-HE Alroy GG Peled R Lavie P . Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome. Eur Neurol 1986; 25: 81–5.

Kumashiro H Sato M Rata JHI “Sleep apnoea” and sleep regulating mechanism—a case effectively treated with monochlor imipramine. Folia Psychiat Neurol 1971; 25: 41–9.

Gurewitz R Blum I Lavie P Recurrent hypothermia, hypersomnolence, central sleep apnea, hypodipsia, hypernatremia, hypothyrodism, hyperprolactinemia and growth hormone deficiency in a boy—treatment with clomopramine. Acta Endocrinol [Suppl] (Copenh) 1986; 279: 468–71.

George CF West P Millar T Kryger MH . Trial of a dopaminergic antidepressant in obstructive sleep apnea. Sleep 1987; 10: 180–3.

Salazar-Grueso EF Rosenberg RS Roos RP . Sleep apnea in olivopontocerebellar degeneration: treatment with trazadone. Ann Neurol 1988; 23: 399–401.

Schmidt HS . L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir 1983; 19: 625–9.

Olson LG Hensley MJ Saunders NA . Breathing during sleep: the responses to asphyxia and prochlorperazine in normal subjects and patients with obstructive sleep apnea. Aust NZ J Med 1983; 13: 613–20.

Goethe B Strohl KP Levin S Cherniack NS . Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 1985; 87: 11–7.

Remmers JE Anch AM Degroot WJ Oropharyngeal muscle tone in obstructive sleep apnea before and after strychnine. Sleep 1980; 3: 447–53.

Guilleminault C Flagg WH Coburn SC Dement WC . Baclofen trial in six myotonic dystrophy patients. Acta Neurol Scand 1978; 57: 232–8.

Tilkian AG Guilleminault C Schroeder JS Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977; 63: 348–58.

Chanson P Timsit J Benoit O Rapid improvement in sleep apnoea of acromegaly after short-term treatment with somatostatin analogue SMS 201–995. Lancet 1986; 1: 1270–1.

Grunstein RR Keating JM Donnelly P Effect of somatostatin on sleep apnea, lung function, and chemosensitivity in acromegaly. Eur Respir J 1988; 1 (suppl): 95S.

He J Kryger MH Zorick FJ Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9–14.